There are no histological differences between anti-CTLA-4- and anti-PD-1/PD-L1-induced colitis [146], except for a more frequent presentation with active colitis and a higher presence of crypt atrophy in patients treated with anti-PD-1 [144]. The gene discussed is CTLA4; the disease is colitis.